Navigation Links
Tekturna Infographic Released by d’Oliveira & Associates Imparts Potential Side Effects of Blood Pressure Drug

(PRWEB) April 18, 2013

Tekturna (aliskiren), produced by Novartis, is a once-daily pill used to treat high blood pressure (hypertension) and is the first “Renin Inhibitor” drug that regulates the renin enzyme in the kidney. This process assists by narrowing the blood vessels and removes water from the bloodstream in order to improve overall circulation (i). In 2011, the FDA determined that aliskiren products had been prescribed over 2.4 million times to over 451,000 patients in the United States (ii). According to the National Institutes of Health, Novartis has marketed aliskiren under the following names: Amturnide, TekAmlo, Tekturna, TekturnaHCT, and Valturna (iii).

According to a press release from Novartis, the company stopped its ALTITUDE medical study in December of 2011 because Tekturna increased the risk of nonfatal stroke, kidney complications, hyperkalemia, and hypotension in patients with Type-2 diabetes. The study was conducted on the part of Novartis in an effort to expand the uses of Tekturna due to the “product profitability in 2011 was negative (iv).” Additional adverse events were recorded by The Institute for Safe Medication Practices in there October of 2012 issue of Quarter Watch which stated that 100 cases of angioedema (swelling) were reported by Tekturna patients in the first quarter of 2012 (v). The same publication also detailed other cases that included one report of death, two reports labeled life threatening, 15 reports of hospitalization, and a final total of 237 Tekturna adverse event reports, “more than any other blood pressure medication (v).”

The infographic issued by d’Oliveira & Associates provides general information on Tekturna as well as lists possible side effects. Side effects allegedly connected to the high blood pressure drug may include: kidney complications, hyperkalemia, angioedema, heart attack, stroke, and/or birth defects. Visit the Tekturna page and view the infographic here: Tekturna Infographic

If you or a loved one has suffered any injuries after taking Tekturna, you may want to file a claim. You should find the best Tekturna lawyer because you may only have one chance at justice. A personal injury lawyer familiar with this blood pressure drug may be able to provide you with important personal and legal advice. d’Oliveira & Associates, P.C., is working with some of the more experienced dangerous drug lawyers who are handling these cases. Please contact the law offices of d’Oliveira & Associates, P.C. at 1-800-992-6878 or fill out a contact form for a free legal consultation.


Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. St Jude Retreats Releases New Infographic Which Reports Consequences of Drunk Driving
2. d'Oliveira & Associates Issues New Infographic on Xarelto Providing Current FDA and Medical Study Information
3. d'Oliveira & Associates Releases New Byetta Infographic on Potential Kidney and Pancreas Health Risks Associated with the Drug
4. IHC Specialty Benefits Releases an Affordable Care Act Infographic to Help Customers Determine Health Insurance Rebates
5. d'Oliveira & Associates Releases Zimmer Knee Infographic Providing Important Safety Information on High-Flex Knees
6. Loyola University New Orleans Presents a History of Nursing in its New Infographic: Nursing Evolution
7. Law Firm Issues Biomet Hip Infographic Warning Consumers About the Dangers of Biomet Hip Implants
8. d'Oliveira & Associates Releases Fresenius Infographic about the FDA Recall of NaturaLyte and GranuFlo
9. d’Oliveira & Associates Releases Mirena IUD Infographic Describing Bayer’s Deceptive Mirena Simple Style Campaign
10. MacGregor & Collins, LLP Releases New California DUI Infographic
11. Get New Patients, INC Releases New Infographic titled 'Are Negative Reviews Killing Your Medical Practice?"
Post Your Comments:
(Date:11/25/2015)... ... 2015 , ... The McHenry County law firm of Botto Gilbert Lancaster, ... Francisco J. Botto and Alex C. Wimmer. Attorneys Botto and Wimmer represented the claimant ... (2d) 130884WC. , According to court documents, Adcock testified that on May 10, 2010 ...
(Date:11/25/2015)... ... ... SCOTTSDALE, AZ) - Today, Dr. Todd C. Hobgood ... non-surgical treatments, announced the expansion of his private practice capabilities with the grand ... trained and nationally recognized for his natural approach, Dr. Todd Hobgood serves the ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted ... in Chicago, IL, UV Angel is evaluating the efficacy of its product and its ... units (totaling 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... scholarships for people struggling with eating disorders as a result of the $20,000 ... annual event, held at Fox Run Golf Club in Eureka, will help individuals ...
(Date:11/25/2015)... Davie, Florida (PRWEB) , ... November 25, 2015 ... ... PharmaTech LLC has announced that it has undertaken significant expansion of its current ... Florida. The investment is part of PharmaTech’s strategy to increase its manufacturing capacity ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... BOULDER, Colo. , Nov. 24, 2015 /PRNewswire/ ... announced that its Chief Executive Officer, Ron ... Annual Healthcare Conference in New York.  The public ... a webcast on the Array BioPharma website.Event:Piper Jaffray ... OfficerDate:  , Wednesday, December 2, 2015Time:1:30 p.m. Eastern ...
(Date:11/24/2015)... New York , 24. November 2015 ... des Avery Breathing Pacemaker Systems, ist erfreut, ... als Clinical Consultant bekannt geben zu können. ...   --> Foto ... Stockholm (Schweden). Von 1984-1986 war ...
(Date:11/24/2015)... 24, 2015 Avery Biomedical Devices (ABD), manufacturer ... announce the appointment of Anders Jonzon , MD; ... Dr. Jonzon is a Physiologist ... Hospital, Uppsala University, Uppsala and Children,s Hospital, Karolinska, ... a fellow at the Cardiovascular Institute (UCSF). His research ...
Breaking Medicine Technology: